
    
      Primary objectives of this research

        1. Evaluate the safety of a combination of TACE and high dose SBRT

        2. Measure time to progression (TTP) and local recurrence rate of HCC treated with a
           combination of TACE & SBRT.

      Secondary objectives of this research

        1. Assess failure patterns and survival of patients treated with TACE & SBRT.

        2. Analyze dose volume characteristics that influence Radiation Induced Liver Disease
           (RILD) among patients treated with a combination of TACE and SBRT.
    
  